CompletedNCT00214877
Methylene blue for cognitive difficulties in bipolarity
About this title
Methylene Blue for Cognitive Dysfunction in Bipolar Disorder
Read the official source — NCT00214877Medication studyAges 18–65Canada
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- Halifax and 1 more locationSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateNovember 2003
- Recruitment status
- Completed
- Enrollment listed in the registry
- 40
- Sponsor
- Nova Scotia Health Authority
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Canada
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00214877
- Official title
Show the full official title
Double-Blind Trial of Methylene Blue for Cognitive Dysfunction in Bipolar Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Halifax · Hamilton
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Nova Scotia Health Authority.
Did this study involve medication?
Yes. The study involved medication, including Methylene Blue.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
